Source:http://linkedlifedata.com/resource/pubmed/id/12133271
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
10
|
pubmed:dateCreated |
2002-7-22
|
pubmed:abstractText |
The adeno-associated viruses (AAV) offer new perspectives for cytokine gene transfer in rheumatoid arthritis (RA) because they are nonpathogenic and allow long-term transgene expression in vivo. Moreover, the use of a tetracycline-inducible promoter allows regulation of therapeutic gene expression. This study assessed the potential long-term gene regulation of a recombinant AAV vector expressing viral interleukin-10 (vIL-10) in human rheumatoid synovium and the therapeutic efficiency in a mouse model of RA. We constructed a recombinant AAV vector in which the transcription of vIL-10 cDNA is controlled by the TetON system. Transduction of human primary RA synovial cells with AAV-tetON-vIL10 conferred in vitro controlled vIL-10 expression. After intramuscular injection, both incidence and severity of collagen-induced arthritis were significantly reduced at macroscopic, radiological, and histological levels in the group of DBA1 mice treated with AAV-TetON-vIL10 vector plus doxycycline after immunization and boosting compared to control groups. When coinjecting two separate AAV vectors, one encoding the inducible vIL-10 and the other the transcriptional activator, a 10 times excess of the transactivator vector dose allowed efficient control of vIL-10 secretion by doxycycline administration or withdrawal, over an 8-week period. Our results supported, for the first time, the utility of AAV-tetON-vIL10 as a therapeutic tool for gene therapy in RA.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jul
|
pubmed:issn |
1043-0342
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
1
|
pubmed:volume |
13
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1179-88
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:12133271-Animals,
pubmed-meshheading:12133271-Arthritis, Experimental,
pubmed-meshheading:12133271-Dependovirus,
pubmed-meshheading:12133271-Gene Expression,
pubmed-meshheading:12133271-Gene Expression Regulation,
pubmed-meshheading:12133271-Gene Therapy,
pubmed-meshheading:12133271-Gene Transfer Techniques,
pubmed-meshheading:12133271-Genetic Vectors,
pubmed-meshheading:12133271-Genome, Viral,
pubmed-meshheading:12133271-HeLa Cells,
pubmed-meshheading:12133271-Humans,
pubmed-meshheading:12133271-Interleukin-10,
pubmed-meshheading:12133271-Male,
pubmed-meshheading:12133271-Mice,
pubmed-meshheading:12133271-Mice, Inbred DBA,
pubmed-meshheading:12133271-Organ Specificity,
pubmed-meshheading:12133271-Tetracycline
|
pubmed:year |
2002
|
pubmed:articleTitle |
Tetracycline-inducible interleukin-10 gene transfer mediated by an adeno-associated virus: application to experimental arthritis.
|
pubmed:affiliation |
Unité de Recherche en Immunopathologie des Maladies Tumorales et Autoimmunes, INSERM U475, France. appara@montp.inserm.fr
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|